Skip to main content
OpenTrials
Completed

NCT Number: NCT01169220

Bowel Preparation for Inpatient Colonoscopy

This study will compare two strategies for bowel cleansing prior to inpatient colonoscopy: the entire preparation taken the night before the procedure versus half the preparation taken the night before the procedure, and the other half taken the morning of the procedure.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • any diagnosis for which colonoscopy is indicated

Exclusion criteria

  • ileus
  • severe colitis/toxic megacolon
  • gastric retention
  • bowel perforation
  • gastrointestinal obstruction
  • gastroparesis that precludes oral bowel preparation
  • pregnant or lactating women
  • allergy to polyethylene glycol.
  • unable to give consent

Treatment and study plan

Go-Lytely

Drug

Bowel cleansing agent

Go Lytely

Drug

Bowel cleansing agent

Primary outcomes

  1. Quality of colon cleansing

    Time frame: 24 hours from study enrollment

Secondary outcomes

  1. Patient satisfaction

    Time frame: 24 hours from study enrollment

Sponsors and collaborators

Lead sponsor

Santa Clara Valley Health & Hospital System

Other

Registry information

Official study title

Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Jul 26, 2010
Registry last updated
Oct 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.